Bausch & Lomb says warning letter issues mainly addressed
This article was originally published in Clinica
Bausch & Lomb says the issues outlined in a warning letter from the FDA dated October 31 have already been largely addressed. The letter refers to the agency's March-May 2006 inspection of the company's Greenville, South Carolina manufacturing site, which culminated in the eye care company recalling its ReNu with MoistureLoc lens care solution following an outbreak of Fusarium keratitis (Clinica passim).
You may also be interested in...
Target guests in selected locations will be able to shop a curated Ulta Beauty section in the second half of 2021. The partnership could attract new clientele to Target stores and give Ulta a boost following nationwide store closures this year due to COVID.
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.